(Q40191072)

English

The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells.

scientific article published on 22 December 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

P Lu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

C Voelkel-Johnson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

327-334

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Signalling in viral entry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Gene therapy scores against cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Adenoviral transgene expression enhanced by cotreatment with etoposide in cultured cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

TRAIL-induced signalling and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

A review of depsipeptide and other histone deacetylase inhibitors in clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701017

21 January 2018

Identifiers

10.1038/SJ.CGT.7701017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186014%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40191072&oldid=2203484686"